Incyte Corp (NASDAQ:INCY)

78.48
Delayed Data
As of Jan 22
 -0.17 / -0.22%
Today’s Change
72.00
Today|||52-Week Range
96.79
-10.12%
Year-to-Date
Incyte Stock Is Down: Buy the Dip?
Jan 15 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
2 Top Growth Stocks to Buy in January
Jan 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close78.65
Today’s open78.83
Day’s range78.22 - 79.53
Volume845,417
Average volume (3 months)1,322,294
Market cap$17.3B
Data as of 4:00pm ET, 01/22/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+269.07%
Earnings growth (next 5 years)+30.50%
Revenue growth (last year)+22.50%
P/E ratio42.0
Price/Sales7.29
Price/Book8.91

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+3.03+2.79%
GLPGGalapagos NV-3.18-1.33%
ALNYAlnylam Pharmaceutic...-2.35-1.99%
MYLMylan NV+0.14+0.65%
Data as of 4:00pm ET, 01/22/2020

Financials

Next reporting dateFebruary 14, 2020
EPS forecast (this quarter)$0.35
Annual revenue (last year)$1.9B
Annual profit (last year)$109.5M
Net profit margin5.82%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Wilmington, Delaware

Forecasts